Cyclerion Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $93 | $81 | $1,806 | $194 |
Gross Profit | 81 | 1,806 | 194 | |
EBITDA | -1,672 | -1,457 | 502 | -1,128 |
EBIT | -1,672 | -1,457 | 502 | -1,128 |
Net Income | -324 | -1,429 | 530 | -723 |
Net Change In Cash | 93 | 81 | 1,806 | 194 |
Free Cash Flow | -503 | -968 | 360 | -1,716 |
Cash | 3,006 | 3,639 | 3,232 | 2,872 |
Basic Shares | 3,071 | 2,556 | 2,545 | 2,526 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,000 | $0 | $297 | $3,320 |
Gross Profit | 2,000 | 232 | 2,848 | |
EBITDA | -3,628 | -12,593 | -18,181 | -55,195 |
EBIT | -3,628 | -9,647 | -18,246 | -55,667 |
Net Income | -3,057 | -21,015 | -43,784 | -51,663 |
Net Change In Cash | 2,000 | 0 | 297 | 3,320 |
Free Cash Flow | -4,333 | -21,245 | -40,611 | -36,524 |
Cash | 3,232 | 7,571 | 13,382 | 53,961 |
Basic Shares | 2,518 | 2,338 | 2,173 | 1,957 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.11 |
2025-03-31 | -$0.55 |
2024-12-31 | $0.20 |
2024-09-30 | -$0.28 |
